Effect of Intravenous Iron Combined With Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) on Ventricular Function and Myocardial Iron Content in Patients With Heart Failure With Reduced Ejection Fraction—Rationale for the COMBINED-HF Study
Fields of Study & Subjects
Iron Metabolism and Disorders
Heart Failure Treatment and Management
Erythropoietin and Anemia Treatment
Publication details
- Journal / source
- Journal of Cardiac Failure
- Volume
- 32
- Issue
- 8
- Pages
- 1389–1395
- Publication date
- 16 February 2026
- Language
- EN